Diamyd Medical Total Risk Alpha
| DMYD-B Stock | | | SEK 13.54 0.80 6.28% |
The Total Risk Alpha signal for Diamyd Medical AB reflects patterns observed in trading data. Availability can differ across markets, exchanges, and instruments. Diamyd Medical has a market cap of 1.21 B, operating margin of -170.83%, ROE of -41.55%. Allocation context is available in
Investing Opportunities. A position in Diamyd Medical AB appears within the mix. Position sizing reflects the allocation methodology applied to the portfolio. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in inflation.
Diamyd Medical AB has current Total Risk Alpha of 1.11. The total risk alpha measures the performance of an asset by comparing its returns with those of a selected benchmark portfolio.
Total Risk Alpha | = | RFR + (ER[b] - ER[a]) | x | STD[a] / STD[b] |
| = | 1.11 | |
| ER[a] | = | Expected return on investing in Diamyd Medical |
| ER[b] | = | Expected return on market index or selected benchmark |
| STD[a] | = | Standard Deviation of returns on Diamyd Medical |
| STD[b] | = | Standard Deviation of selected market or benchmark |
| RFR | = | Risk Free Rate of return. Typically T-Bill Rate |
Total Risk Alpha Peers Comparison
Total Risk Alpha Relative To Other Indicators
Diamyd Medical AB ranks first in total risk alpha among leading competitors. It is currently under evaluation in maximum drawdown among leading competitors reporting about
20.46 of Maximum Drawdown per Total Risk Alpha. At
20.46 , Diamyd Medical AB's Maximum Drawdown-to-Total Risk Alpha multiple reflects the spread between these metrics
The benchmark portfolio represents the market risk matched to the total risk of the stock ETF or fund.
Compare Diamyd Medical to Peers
Other Technical Indicators